| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 56 |
| 1 | METHOTREXATE | 46 |
| 2 | LEFLUNOMIDE | 43 |
| 3 | HYDROXYCHLOROQUINE SULFATE | 42 |
| 4 | SULFASALAZINE | 40 |
| 5 | RITUXIMAB | 38 |
| 6 | PREDNISONE | 37 |
| 7 | DICLOFENAC | 27 |
| 8 | DICLOFENAC SODIUM | 27 |
| 9 | PREGABALIN | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROCORTISONE BUTYRATE | 8 | 0.0040 |
| 1 | CAFFEINE CITRATE | 8 | 0.0034 |
| 2 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 2 | 0.0030 |
| 3 | PIROXICAM | 12 | 0.0019 |
| 4 | TRICLOSAN | 1 | 0.0017 |
| 5 | DESOGESTREL AND ETHINYL ESTRADIOL | 5 | 0.0015 |
| 6 | PSEUDOEPHEDRINE HCL | 14 | 0.0013 |
| 7 | NAPROXEN SODIUM 220MG | 17 | 0.0012 |
| 8 | PREDNISOLONE SODIUM PHOSPHATE | 3 | 0.0012 |
| 9 | 12%AZELAIC ACID | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 53 |
| 1 | Corticosteroid [EPC] | 47 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 46 |
| 3 | Antirheumatic Agent [EPC] | 43 |
| 4 | Aminosalicylate [EPC] | 40 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 38 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 27 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 25 |
| 8 | Vitamin C [EPC] | 24 |
| 9 | Interleukin-12 Antagonist [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 9 | 0.0049 |
| 1 | Bile Acid Sequestrant [EPC] | 5 | 0.0004 |
| 2 | Antirheumatic Agent [EPC] | 43 | 0.0004 |
| 3 | Provitamin D2 Compound [EPC] | 12 | 0.0004 |
| 4 | Aminosalicylate [EPC] | 40 | 0.0004 |
| 5 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 6 | Bile Acid [EPC] | 5 | 0.0002 |
| 7 | beta3-Adrenergic Agonist [EPC] | 10 | 0.0002 |
| 8 | Interleukin-12 Antagonist [EPC] | 21 | 0.0002 |
| 9 | Interleukin-23 Antagonist [EPC] | 21 | 0.0002 |